Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Acetylcysteine is the active ingredient of these drugs:
United Kingdom
Ecuador
United Kingdom
United States
United Kingdom
Ecuador
Hong Kong
Hong Kong
Hong Kong
Hong Kong
Austria
Ecuador
Brazil
South Africa
Ecuador
Lithuania
Hong Kong
Ecuador
Ecuador
Finland
Netherlands
Spain
Brazil Germany
Estonia
Ecuador
Tunisia
Ecuador
Brazil
Hong Kong
Brazil
Hong Kong
Hong Kong
Ecuador
Ecuador
Austria
Ecuador
France
Ecuador
Ecuador
Ecuador
Brazil Ecuador
Ecuador
Ecuador
Ecuador
Ecuador
Austria Brazil Ecuador Estonia France
Brazil
Spain
Spain
Hong Kong
France Hong Kong Singapore Spain
Austria
United Kingdom
France
South Africa
Finland
Ecuador
Singapore
Hong Kong
Tunisia
South Africa
Poland
Estonia
South Africa
Poland
Austria
France
Poland
South Africa
South Africa
Tunisia
Ecuador
Finland France
Finland
Hong Kong
Hong Kong
Tunisia
Ecuador
Hong Kong
Singapore
Ireland United Kingdom
Ecuador
Spain
South Africa
Ireland South Africa United Kingdom
Brazil
Brazil
Lithuania Poland
Ecuador
Cyprus Hong Kong South Africa
Singapore
Singapore
Hong Kong
Ecuador
Ecuador
Hong Kong Ireland
Cyprus Singapore
Poland
South Africa
Ecuador
Estonia
Acetylcysteine is also found within below combination drugs:
ACEMUK BIOTIC DUO , ACEMUK L , AMINOPLASMAL , AMINOSTERIL N HEPA , DRENAFLEN GRIPE , FLEMISOL GRIPE , FLEMISOL GRIPE NINOS , FLUIMUCIL ANTIBIOTIC , NEPHROSTERIL , NORMOTEMP AF , RHINOFLUIMUCIL , RINOFLUIMUCIL